Global Obesity Management Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.
North America is forecast to account for more than 1/3 revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2025.

Market Analysis and Insights: Global Obesity Management Market
The research report studies the Obesity Management market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Obesity Management market size is projected to reach US$ 7694.8 million by 2026, from US$ 5820.4 million in 2020, at a CAGR of 4.8% during 2021-2026.

Global Obesity Management Scope and Segment
The global Obesity Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Segment by Type, the Obesity Management market is segmented into
Drug
Surgery

Segment by Application, the Obesity Management market is segmented into
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies

Global Obesity Management market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The major vendors covered:
Roche
GlaxoSmithKline
Orexigen Therapeutics
Arena Pharmaceuticals
VIVUS
Novo Nordisk